This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
4 MedTech Stocks Up More Than 100% in 2020 With Room to Run
by Urmimala Biswas
We discuss four MedTech stocks, CDNA, FLGT, OMI and QDEL that more than doubled in 2020, and are poised to maintain market beating momentum in 2021 on strong fundamentals.
Zacks.com featured highlights include: AutoNation, Laboratory Corporation, OMI, TTEC and ArcBest
by Zacks Equity Research
Zacks.com featured highlights include: AutoNation, Laboratory Corporation, OMI, TTEC and ArcBest
Agios (AGIO) to Sell Oncology Drugs to Servier for $2B, Stock Up
by Zacks Equity Research
Agios (AGIO) sells its oncology business unit to French company Servier for around $2 billion. The company plans to solely focus on developing treatments for genetically defined diseases. Shares rise.
Bet on These 5 Stocks With Upgraded Broker Ratings Right Now
by Swayta Shah
After thorough research, brokers rate particular company's stock. So, we pick Hain Celestial (HAIN), Owens & Minor (OMI), Myers Industries (MYE), Owens Corning (OC) and Manpower (MAN) as these witness ratings upgrade.
6 Stocks Near 52-Week Highs That are Poised to Rally Further
by Anirudha Bhagat
Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.
AtriCure (ATRC) Looks Good: Stock Adds 5.1% in Session
by Zacks Equity Research
AtriCure (ATRC) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Top Ranked Growth Stocks to Buy for December 21st
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 21st
Top Ranked Growth Stocks to Buy for December 16th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 16th.
Top Ranked Growth Stocks to Buy for December 14th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 14th.
Top Ranked Growth Stocks to Buy for December 11th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 11th
The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic
Is Owens & Minor (OMI) a Worthy Pick for Value Investors?
by Zacks Equity Research
Let's see if Owens & Minor (OMI) stock is a good choice for value-oriented investors right now from multiple angles.
Zacks.com featured highlights include: Innoviva, Owens & Minor, Standard Motor Products, NIC and California Water Service
by Zacks Equity Research
Zacks.com featured highlights include: Innoviva, Owens & Minor, Standard Motor Products, NIC and California Water Service
4 Top-Ranked MedTech Stocks to Bet on Heading Into 2021
by Trina Mukherjee
Grab these four top stocks that have shown tremendous promise despite market volatility due to the pandemic and have the potential to continue their bull run in 2021.
6 Stocks Near 52-Week Highs Poised to Rally Further
by Anirudha Bhagat
Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.
Buy These 5 Low-Beta Stocks to Combat a Choppy Market
by Nilanjan Banerjee
To combat market volatility, it is of utmost importance to create a portfolio of low-beta stocks.
Top Ranked Growth Stocks to Buy for December 7th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 7th
Agios' (AGIO) Phase III Study on Mitapivat Meets Primary Goal
by Zacks Equity Research
Agios' (AGIO) phase III ACTIVATE study evaluating mitapivat for addressing PK deficiency in patients with no regular blood transfusions achieves the primary goal.
Top Ranked Growth Stocks to Buy for December 2nd
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 2nd.
Top Ranked Growth Stocks to Buy for December 1st
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 1st.
5 Top-Ranked Growth Stocks to Buy Instead of Bitcoin
by Aniruddha Ganguly
Here we pick five stocks -- OMI, NLS, TTD, OSTK, FVRR -- that have surged more than 200% this year and are safer investment choices than cryptocurrencies.
New Strong Buy Stocks for November 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Top Ranked Growth Stocks to Buy for November 27th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, November 27th
10 Stocks That Deserve Thanks in Pandemic-Ravaged 2020
by Sweta Killa
While the gains are broad based, we have highlighted 10 stocks - APPS, OMI, EXPI, TUP, STKL, CALX, VSTO, CMBM, QDEL and AVNW - that have been on the forefront of the rally this year.
Top Ranked Growth Stocks to Buy for November 20th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, November 20th